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ABSTRACT (257 words): 
Background and Aims: α1-antitrypsin deficiency (A1ATD) is an autosomal 
recessive disorder caused by mutations in the SERPINA1 gene. Individuals 
with the Z variant (Gly342Lys) retain polymerised protein in the endoplasmic 
reticulum (ER) of their hepatocytes, predisposing them to liver disease. The 
concomitant lack of circulating A1AT also causes lung emphysema. Greater 
insight into the mechanisms that link protein misfolding to liver injury will 
facilitate the design of novel therapies.  
Methods: hiPSC-derived hepatocytes provide a novel approach to interrogate 
the molecular mechanisms of A1ATD because of their patient-specific genetic 
architecture and reflection of human physiology. To that end, we utilised 
patient-specific hiPSC hepatocytes (ZZ-HLCs) derived from an A1ATD (ZZ) 
patient, which faithfully recapitulated key aspects of the disease at the 
molecular and cellular level. Subsequent functional and “omics” comparisons 
of these cells with their genetically corrected isogenic-line (RR-HLCs) and 
primary hepatocytes/human tissue allowed the identification of new molecular 
markers and disease signatures.  
Results: Our studies showed that abnormal A1AT polymer processing 
(immobilized ER components, reduced luminal protein mobility and disrupted 
ER cisternae) occurred heterogeneously within hepatocyte populations and 
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was associated with disrupted mitochondrial structure, presence of the 
oncogenic protein AKR1B10 and two upregulated molecular clusters centred 
on members of inflammatory (IL-18 and Caspase-4) and unfolded protein 
response (Calnexin and Calreticulin) pathways. These results were validated 
in a second patient-specific hiPSC line. 
Conclusions: Our data identified novel pathways that potentially link the 
expression of Z A1AT polymers to liver disease. These findings could help 
pave the way towards identification of new therapeutic targets for treatment of 
A1ATD. 
 
LAY SUMMARY:  
This study compared the gene expression and protein profiles of healthy liver 
cells and those affected by the inherited disease α1-antitrypsin deficiency. This 
approach identified specific factors primarily present in diseased samples 
which could provide new targets for drug development. This study also 
demonstrates the interest of using hepatic cells generated from human 
induced pluripotent stem cells to model liver disease in vitro for uncovering 
new mechanisms with clinical relevance.  
 
GRAPHICAL ABSTRACT: Attached 
 
HIGHLIGHTS:  
•  Modelling α1-antitrypsin deficiency liver disease using hiPSC-derived 
hepatocytes reveals disruption of the endoplasmic reticulum into 
isolated cisternae.   
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• Comparative transcriptomic and proteomics between diseased hiPSC-
derived hepatocytes and their isogenic wildtype provides insights into 
disease mechanisms.  




α1-antitrypsin (A1AT) is a 52 kDa protein encoded by the SERPINA1 gene 
synthesized primarily by hepatocytes [1]. Secreted into the blood stream, it 
acts to control the function of neutrophil elastase, particularly in the lung [2]. 
A1AT also exerts anti-apoptotic and anti-inflammatory properties during 
inflammation and hepatic injury. Most people carry the wildtype M allele, while 
the rarer Z variant (found in 1-3% of the population), is associated with the 
most common and severe form of clinically significant A1AT deficiency 
(A1ATD) [3]. The Z allele is caused by a Glu342Lys mutation in exon 5 of the 
SERPINA1 gene, leading to conformational instability within the protein [4]. 
Approximately 70 % of synthesized Z A1AT is degraded by intracellular quality 
control mechanisms, 15 % is secreted whilst the remaining 15 % accumulates 
in hepatocytes as ordered polymers. These polymers are associated with 
neonatal hepatitis, cirrhosis and hepatocellular carcinoma. Furthermore, the 
significant reduction in circulating plasma A1AT levels leads to uncontrolled 
proteolytic activity within the lung and development of early onset panlobular 
emphysema [5]. 
Despite the recognition of A1ATD over fifty years ago [6], the detailed 
molecular mechanisms linking A1AT polymer accumulation to the 
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development of liver disease remain poorly understood. This has been 
hampered by the availability of primary human hepatocytes expressing 
wildtype and mutant forms of A1AT capable of surviving in culture long-term. 
Although the use of animal models and artificial A1AT-expressing cell systems 
have contributed significantly to improved understanding of the disease 
processes [7] [8] [9], multiple gene copies, interference of endogenous animal 
antiproteases, lack of pathological features post-polymer accumulation, and 
the absence of endogenous promoters to activate gene expression represent 
challenges for translating new findings in these model systems to man.  
The advent of human induced pluripotent stem cells (hiPSCs) [10] has 
provided an exciting platform to address these obstacles. Indeed, PiZZ 
hiPSCs (ZZ-hiPSCs) derived from patients with A1ATD were shown to 
differentiate into hepatocyte-like cells (ZZ-HLCs) that recapitulate the modified 
post-translational processing and secretion kinetics of mutant A1AT [11] [12]. 
Furthermore, patient-specific HLCs were genetically corrected to erase the 
disease signature (RR-HLCs) [13] and so generated a perfect control cell line 
with which to perform mechanistic studies. 
Using these tools, we first established the suitability of HLCs to study 
the mechanisms of A1ATD by benchmarking their gene expression, protein 
synthesis and metabolic activity against primary hepatocytes. Then, by 
comparing the transcriptome and ER-enriched proteome of ZZ- and RR-HLCs, 
we validated the platform’s efficiency for identifying novel biomarkers and 
pathways involved in mediating the disease processes that may be of 




MATERIALS AND METHODS:  
hiPSC culture and hepatic differentiation 
All hiPSC lines used in this study have were derived as previously described 
[11] under Addenbrooke’s Hospital Ethics reference number 08/H0311/201; 
R&D No. A091485. These cells were maintained at 37 °C in humidified 
incubators supplemented with 5 % v/v carbon dioxide and were differentiated 
using our established hepatic differentiation protocol with minor modifications 
[14]: Cells were differentiated at 5 % oxygen and two splitting steps allowed 
for scale-up and prolonged maturation of differentiating cells (Supplementary 
Fig. 1A). During the splitting steps on day 8 and day 25, cells were washed 
with PBS and dissociated with TrypLETM (Life Technologies, 12563-029) for 
20-45 min at 37 °C. Harvested cells were centrifuged at 100 x g for 3 min. 
Cells were resuspended in RPMI (day 8 split) or HepatoZYME-SFM (day 25) 
(Thermo Fisher, 17705-021). Cells were counted and resuspended in RPMI 
and Activin (day 8 split) or HepatoZYME-SFM (Thermo Fisher, 17705-021), 
OSM and HGF (day 25 split), supplemented in each case with ROCK inhibitor 
(1 µL/mL) to a concentration of 210,500 cells/cm2.  
 
Primary hepatocyte procurement 
Commercially plated human primary hepatocytes from two donors were 
purchased from Biopredic International (France). The cells exhibited viabilities 
between 88-93% after isolation, fulfilled the manufacturer’s requirements of 
Phase I and II-dependent enzyme activities and were cultured for 48 h in 
hepatocyte medium prior to harvesting. Fresh human primary hepatocytes 
were kindly provided by Dr. Roque Bort with approval of the hospital’s ethics 
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committee (Instituto de Investigación Sanitaria La Fe, Valencia, Spain). Upon 
isolation, hepatocytes were snap frozen and the resulting cell pellets were 
directly lysed for RNA extraction.  
 
RNA-seq 
Library preparation of RNA samples were performed with the Illumina TruSeq 
RNA Sample Preparation V2 assay. Samples were multiplexed on two lanes 
with 40 bp (HLCs) or 75bp (PiZZ/PiMM) read lengths, single strand and 
single-end (HLCs) or paired-end (PiZZ/PiMM) reads and generated ~16.5 
million reads per sample on the Illumina HiSeq 2000. Bioinformatic analysis 
were carried out following standard procedures [11] and of raw data are 
available on arrayexpress accession number E-MTAB-6781. 
 
RESULTS: 
hiPSC-derived hepatocyte-like cells are suitable for modelling human 
disease  
We have previously generated disease specific hiPSCs (ZZ-hiPSCs) [11] and 
created an isogenic wildtype line (RR-hiPSC) using genome editing [13]. Once 
differentiated, ZZ-derived hepatocyte like cells (ZZ-HLC) displayed 
intracellular polymer retention whilst corrected cells (RR-HLC) secreted 
normal levels of A1AT. Thus, RR-HLC represent the ideal control for 
molecular studies since phenotypic differences observed between both cell 
types should exclusively be attributable to the misfolding of mutant A1AT in 
HLC-ZZs and not to variability between hiPSCs lines of different genetic 
backgrounds [15]. To further validate this hypothesis, we compared the 
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hepatic function of ZZ-HLCs and RR-HLCs using as positive control primary 
hepatocytes freshly isolated, cryopreserved or freshly plated. Of note, we 
applied an optimised protocol [14] allowing HLCs to differentiate for an 
extended period of time and thus to increase their functional repertoire 
(Supplementary Fig. 1A-C). As expected, HLCs expressed a diversity of 
hepatic markers including A1AT, ALB and HNF4α at levels equivalent to 
primary hepatocytes (Fig. 1A-C). They also displayed CYP3A4 expression 
and activity although at significantly lower levels than primary cells (Fig. 1A, 
Supplementary Fig. 1B). Reversely, HLCs showed expression of foetal 
markers CYP3A7 and AFP at higher levels (Fig. 1A) thereby confirming their 
foetal identity [16]. More importantly, ZZ-HLCs and RR-HLCs expressed 
comparable levels of hepatic markers (Fig. 1A). These observations were 
confirmed by immunostaining and DELFIA, showing these markers to be 
expressed at equivalent levels in both cell types with the exception of A1AT, 
which was synthesised in lower concentrations into ZZ-HLCs culture media 
(Fig. 1B-C). To confirm this observation, A1AT trafficking in ZZ-HLCs was 
assessed by growing HLCs in the presence of radioactively labelled [35S] 
Cys/Met and by subsequently tracking its transition from the intracellular to the 
extracellular space over the course of four hours. The band intensities of 
these pulse-chase experiments revealed a slower rate of glycoprotein 
maturation (e.g. sialic acid residue incorporation) and trafficking of A1AT to 
the extracellular space in ZZ-HLCs (Fig. 1D). Whilst wildtype A1AT was 
almost fully secreted after four hours in RR-HLCs, mutant A1AT in ZZ-HLCs 
was mostly degraded or retained intracellularly during the same time period 
[17]. Taken together, these results demonstrate that ZZ-HLCs and RR-HLCs 
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have reproducible biological characteristics in vitro except for the processing 
of A1AT and therefore provide a suitable control-study pair for in-depth 
characterisation of the disease pathophysiology of A1ATD. 
 
ZZ-HLCs abnormally process A1AT polymer in a heterogenous, ER-
dependent manner 
To investigate the impact of A1AT protein accumulation on cellular trafficking, 
we studied the hepatic endoplasmic reticulum (ER) – the site at which mutant 
A1AT proteins aggregate – at a single cell level. ZZ- and RR-HLCs were 
transfected with the ER marker GFP-KDEL that has been shown to co-localise 
with A1AT polymers [9]. Transfections of HLCs with the GFP-KDEL construct 
yielded a population of RR-HLCs which all contained normal, reticular ER 
morphologies (Fig. 2A). In contrast, ZZ-HLCs frequently displayed large ER 
inclusions. We classified these as inclusions of small, medium or large size 
and quantified the percentage of cells containing each sub-type (Fig. 2B). 
Overall, 40 % of ZZ-HLCs showed inclusions, whilst the remaining 60 % of 
cells exhibited a normal ER. We next assessed for the effect of intracellular 
inclusions on ER architecture using “Fluorescence Loss In Photobleaching” 
(FLIP) and “Fluorescence Recovery After Photobleaching” (FRAP) to track 
live, GFP-KDEL transfected ZZ-HLCs and RR-HLCs [18]. This allowed an 
evaluation of the cell’s ER connectivity (FLIP) and luminal protein mobility 
(FRAP) by monitoring the diffusion rates of inert fluorescent probes throughout 
different ER morphologies. Repeated photobleaching of a pre-defined 
fluorescent region resulted in complete depletion of fluorescence in inclusion-
free ZZ- and RR-HLCs, while neighbouring cells were unaffected (Fig. 3A). Of 
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particular note was the small, consistent recovery of fluorescence in between 
the bleaching events, suggesting rapid diffusion of unbleached KDEL-
fluorophores back to the area of interest. These observations reinforced our 
previous results obtained on transformed cell lines [19] by showing that in 
wildtype HLCs, ER proteins can sample distant compartments of the ER by 
diffusion when enclosed by connected, tubular ER luminae. In contrast, in 
inclusion-bearing ZZ-HLCs, FLIP within large inclusions resulted in the 
localised loss of KDEL-GFP fluorescence with no recovery of fluorescence 
after bleaching events. Furthermore, neighbouring inclusions were not 
affected, indicating walled-off ER cisternae with no or restricted ability for 
protein diffusion or interactions between them. These observations were 
further confirmed using another fluorescent protein chimera, the cytoplasmic 
domain of an ER signal anchor membrane protein (CytERM) [20]. FLIP 
performed on ZZ-HLCs with large inclusions transfected with fluorescent 
CytERM resulted in complete loss of fluorescence of the inclusion’s ER 
membrane, whilst neighbouring inclusions were unaffected (Fig 3B). Finally, 
fragmentation and isolation of ER inclusions were confirmed using Z-stack 
images captured across ZZ-HLCs transfected with the fluorescent ER 
membrane protein (Fig. 3C). The mobility of ER proteins was then quantified 
using FRAP assays [18]. The pre-bleach fluorescence level of a selected 
region of interest inside the cytoplasm was normalised to 100% and a single 
bleaching event was performed within the region of interest. Diffusion rates of 
unbleached KDEL-GFP molecules from adjacent areas into the bleached 
region were determined by monitoring the restoration of fluorescent levels into 
the region of interest. We observed that the patterns of fluorescent recovery 
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were similar within regions of reticular ER in RR- and ZZ-HLCs (Fig. 4A). 
Mapping the percentage of fluorescent rescue to the area of bleach showed 
almost immediate recovery at approximately 60 %, which was further restored 
to nearly 90 % in RR-HLCs. In contrast, inclusion-bearing ZZ-HLCs showed 
recovery of only 30-40 % of the original KDEL-GFP fluorescence. Regression 
analysis to reveal the rates of recovery, i.e. the slope of the respective 
fluorescent recovery curves, confirmed faster diffusion rates of proteins in 
areas of connected reticular ER compared to that seen in areas with disrupted 
ER morphologies (RR-HLC: 2.92 ± 0.75, ZZ-HLC no inclusions: 3.99 ± 1.03, 
ZZ-HLC with inclusions 1.23 ± 0.22). There appeared no or very small 
recovery of fluorescence in bleaching of larger inclusions, suggesting a size-
dependent isolation of inclusions (Fig. 4B). To quantify the percentage of total 
fluorescent molecules that contribute to the fluorescent recovery of the 
photobleached area during the assayed time frame, we assessed the mobile 
fractions associated with individual ER morphologies. These showed that 
protein viscosities of reticular ER morphologies were significantly lower than 
that of fractionated ER sites (p ≤ 0.0001) (Fig. 4C). In summary, these data 
showed that polymer accumulation in A1ATD reduced ER protein diffusion 
rates suggestive of immobilised ER components, reduced protein mobilities 
and/or disrupted ER cisternae in inclusion-bearing ZZ-HLCs [21].  
 
Transcriptome and proteome analyses suggest ZZ-HLCs acquire 
mitochondrial abnormalities and are poised for malignancy  
Given the abnormalities in protein mobility observed in the ER, we 
hypothesised that polymer accumulation in ER inclusions could be associated 
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with specific proteins inhibiting A1AT polymer degradation and eliciting stress 
responses [22] [23] [24]. To investigate this hypothesis, we performed 
proteomic analyses on ER fractions isolated from ZZ- and RR-HLCs (Fig. 5A). 
Three independent batches of ZZ- and RR-HLCs were fractionated into their 
subcellular ER fractions and analysed by label-free mass spectrometry. We 
identified 2683 unique proteins in the ZZ- and RR-HLC ER proteomes, which 
were enriched most significantly for the ER (adjusted p-value: 7.1-91) and 
mitochondria (adjusted p-value: 1.6-172). Among these proteins, 14 were 
exclusively identified in all three batches of ZZ-HLCs whilst 3 proteins were 
present only in the RR-HLCs (Fig. 5B). By GO Enrichment Analysis, these 17 
proteins with strict distribution patterns displayed a diversity of functions 
involved in intracellular trafficking, extracellular matrix organization and 
enzymatic activity. Five of these proteins (29%) were attributed to 
mitochondrial localization and oxidoreductase activity: GLUD2, GFER, 
OXCT1, EARS2 and ADCK3. In order to further understand the implications of 
A1AT protein accumulation on a whole-cell scale, genome-wide RNA 
sequencing (RNA-seq) was performed on ZZ-HLCs and RR-HLCs. Statistical 
analysis revealed 1675 genes with significantly different expression (false-
discovery rate (FDR) <5 %), the majority of which were protein-coding genes 
(93.4 %) (Fig. 5C). Of the 1675 differentially expressed genes, 959 were 
upregulated in ZZ-HLCs (958 of them with a fold change >1.5), while 716 
genes were downregulated in ZZ-HLCs (715 of them with a fold change <-
1.5). 319 genes with differential transcript expression were also detected in 
the mass-spectrometry dataset (Fig. 5D). We then combined both proteomic 
and transcriptomic data sets by considering differential abundances of 
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proteins and genes with log-fold changes >2 or <-2. Candidate markers that 
fulfilled these parameters included 18 upregulated and 15 downregulated 
genes/proteins (Fig. 5E), of which 15 % were ER-localised proteins (CLGN, 
KDELR3, COL4A1, COL14A1, CYP1A1). Of note, the low correlation of data 
points seen under these conditions may be explained by the comparison of 
whole-cell transcriptomes with subcellular ER-specific proteomes. We next 
focused on examining the absolute gene expression of the assayed genes 
and considering ZZ-HLCs as the reference. We found that 20 of the 21 most 
highly-expressed and differentially upregulated genes in ZZ-HLCs were of 
mitochondrial origin (Fig. 5F). The majority of their functional repertoire was 
relevant to oxidoreductase activity and mitochondrial ATP synthesis in the 
electron transport chain and included NADH dehydrogenases, ATP 
synthases, cytochromes b and c. The only non-mitochondrial gene in the very 
highly-expressed, upregulated gene cluster was fibrinogen gamma chain 
(FGG), upregulation of which has previously been associated with hepatic 
inflammation [25] and hepatocellular carcinoma [26]. Other molecules with 
reported oncogenic associations were also found in the highly-expressed, 
upregulated cluster and included H19 [27], SPARC [28] and SERPINE1 [29]. 
Furthermore, gene ontology (GO) over-representation analyses on all highly-
expressed, upregulated genes revealed that the five most enriched and 
significant GO terms were tied to extracellular matrix genes associated with 
fibrosis and cirrhosis (p-values <0.0001), a hallmark of liver disease in A1ATD 
(Fig. 5G). This included collagen-related genes (e.g. COL1A1, COL1A2, 
COL3A1, COL4A1 and COL5A1) and genes whose products are involved in 
the assembly and remodelling of the extracellular matrix such as ADAM 
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metallopeptidases (e.g. ADAM19), fibrillin (e.g. FBN1), fibronectin (e.g. FN1), 
laminins (e.g. LAMB1), thrombospondin (e.g. THBS1) and matrix-associated 
proteins encoded by SPARC and WNT5A. Taken together, these analyses 
uncovered highly relevant proteins involved in the response to SERPINA1 
mutations.  
 
Validation of discoveries from the hiPSC-derived hepatocyte platform  
We concluded that overall, several new areas of A1AT-deficient biology in 
HLCs were identified and warranted follow up. The most significant of which 
were: (1) A1AT polymers accumulated in a heterogenous manner within ZZ-
HLC hepatocyte populations, (2) specific proteins associated with 
predisposition to malignancy were found to be highly upregulated in ZZ-HLCs, 
(3) mitochondrial biology in ZZ-HLCs was abnormally affected, and (4) ZZ-
HLCs displayed activation of important inflammatory and unfolded protein 
response pathways. To validate the relevance of these findings, we next 
assessed the accumulation of A1AT polymers in liver tissue from individuals 
with PiZZ A1ATD [30] (Fig. 6A). While the majority of hepatocytes exhibited no 
polymer accumulation, those displaying characteristic A1AT inclusions were 
mainly located at the periphery of hepatic lobules, thereby validating the cell-
to-cell heterogeneity of polymer formation observed in ZZ-HLCs (Fig. 2A). We 
next compared genes differentially expressed in HLCs (ZZ-HLCs vs RR-
HLCs) and primary hepatocytes (PiZZ vs PiMM) and found 80 upregulated 
genes common to both datasets (Fig. 6B). One of these 80 genes (AKR1B10) 
had a related enzyme product (AKR1B1) present exclusively in the ER-
enriched proteome dataset of ZZ-HLCs (Fig. 5B) and a log2-fold change of 3.6 
  
 16 
and 3.8 in differential gene expression between ZZ/RR-HLCs and PiZZ/PiMM 
hepatocytes respectively. The clinical significance of this molecule was 
assessed by immunostaining paraffin-embedded liver sections from three 
patients with PiZZ whose clinical backgrounds (age, sex and severity of 
disease) matched that of the original hiPSC line donor. Samples stained 
positively for AKR1B10 in clusters of cells that were also positive for polymers 
of A1AT (Fig. 6C). Having demonstrated the potential clinical relevance of the 
data generated from our in vitro model for biomarker discovery, we next 
sought to explore physiological pathways that may be underpinning A1AT 
pathogenesis by focusing on GO terms associated with unfolded protein 
binding. Utilizing STRING v9.1, we surveyed known and predicted protein-
protein interactions encoded by those genes upregulated with the highest 
confidence view (score = 0.900) in ZZ-HLCs. We found evidence of gene 
network clusters indicating inflammatory (e.g. IL18) and cellular stress 
responses, (e.g. calnexin (CANX), calreticulin (CALR), BiP/GRP78 (HSPA5), 
ERdj5 (DNAJC10), ERdj6 (DNAJC3), DNAJB11, GRP94 (HSP90B1) and 
GRP170 (HYOU1) (Supplementary Fig. 2). The differential gene expression 
profile of ZZ-HLCs not only appeared to mirror components of the A1AT-
deficient pathology that have previously been identified (e.g. CANX and 
CALR), but also uncovered new genetic networks. Of particular interest were 
those genes linking misfolding-induced inflammatory responses to 
mitochondrial abnormalities since our electron microscopy studies 
demonstrated ZZ-HLC populations contained markedly abnormal 
mitochondrial phenotypes (Fig. 6D), as also previously described in human 
tissue and HLCs [31]. We sought to validate the importance of these genes by 
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examining differential gene expression at the nexus of inflammatory (IL-18 
and CASP4) and unfolded protein (CANX and CALR) clusters in a second 
hiPSC cell model of A1ATD derived from a different patient in a different 
laboratory [32]. All four genes were also found to be upregulated in PiZZ 
versus PiMM cells, suggesting their importance for future investigations 
(Supplementary Fig. 3). Taken together, these data demonstrated that the 
biomarkers and putative new mechanisms identified by our approach could be 
clinically relevant for a broad number of A1AT-deficient patients. 
 
DISCUSSION: 
Despite the classification of A1ATD as a monogenetic disease, the underlying 
molecular mechanisms causing liver pathology are poorly understood. hiPSCs 
offer an appealing model to interrogate such questions but have until now 
been hampered by concerns over whether in vitro signatures reflect the 
human disease. To address this, our study characterised the molecular and 
cellular signatures of ZZ-HLCs in comparison to human tissue. We first 
determined that, as in patients, only a subset (~40 %) of ZZ-HLCs contained 
A1AT polymers and that these polymers are contained within the ER but 
physically isolated from the rest of the ER lumen. Of note, Tafaleng et al. 
previously utilised ZZ-HLCs and ZZ liver samples to establish the presence of 
globular inclusions and dilated ER [12]. Our studies elaborate on these 
observations by using ZZ/RR-HLCs to provide real-time proof of physical ER 
fractionation and absent functional connection between abnormal ER 
structures. Importantly, our analyses of liver samples from patients with 
A1ATD also suggest that the disease could be regionalised as these globular 
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inclusions were mainly located in the lobule periphery. Thus, disease 
progression mechanisms could be associated with liver zonation. To further 
shed light on the molecular mechanisms governing this specific type of 
intracellular A1AT retention, we then compared genome-wide RNA-seq and 
ER-specific proteomic datasets of ZZ-HLCs versus RR-HLCs. The foremost 
misregulated pathways, both on a transcriptomic and proteomic level, were 
associated with known pathways of the misfolded protein response. In 
addition, our analyses also revealed novel molecular proteins and pathways 
important in chaperone function, inflammation, mitochondrial dysfunction and 
malignancy, which we validated in human tissue.  
Despite the persistent molecular and functional similarities of HLCs with foetal 
hepatocytes [33], this work has shown the adequacy of ZZ-HLCs to replicate 
the molecular pathways of PiZZ hepatocytes. Their developmental immaturity 
offers the opportunity to study the emergence, early onset and progression of 
A1ATD, even at stages in which the disease is still asymptomatic in most 
patients [34]. A good example of this is the photobleaching assays (Fig. 3+4), 
which clearly demonstrated that ZZ-HLCs have significant loss of protein 
mobility, ER luminal communication and in some cases complete disruption of 
ER cisternae into isolated units. Whilst it has previously been demonstrated 
that even small deviations in protein diffusion rates can lead to biologically 
relevant changes [35], our observations offer a novel insight into the sub-
cellular anatomy of how this occurs in A1ATD. Such understanding is likely to 
be of clinical significance since cells harbouring fragmented ER inclusions 
have been shown to be more prone to apoptotic cell death and rely on 
replacement by globule-devoid hepatocytes with enhanced cell division rates 
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[36] [37]. However, whether A1AT polymer sequestration into globules is a 
protective cellular response or signals a state of injury in this setting (or even 
both) [37] [38] is currently not known. Further in vitro studies, combined with 
human histological specimens and clinical data may allow us to deconstruct 
this problem by examining whether there is a link between the severity and 
number of ER inclusions, and an association between the severity and 
progression of liver disease. In a similarly important and clinically relevant 
manner, early identification of A1AT-deficient patients who are likely to 
progress to cancerous states represents an unmet but urgently required 
clinical challenge. Whilst AKR1B10 has been associated with hepatocellular 
carcinoma [39] [40], its co-localisation within cells containing polymers (Fig. 
6C) suggests an association of this protein with A1ATD. The presence of 
AKR1B10 may therefore be a direct consequence of polymerised protein 
accumulation, characterising a sub-set of hepatocytes primed towards 
malignancy, making AKR1B10 a potential tissue biomarker for hepatocellular 
carcinoma risk stratification. Other proteins with known liver/cancer 
associations such as cysteine cathepsin family member CTSO [41] [42] were 
also identified in our ZZ-HLC cells and may similarly provide prognostic and 
mechanistic insights into why individuals with A1ATD are at increased risk of 
tumourigenicity [43].  
Understanding molecular pathways linking the polymerisation of Z A1AT to 
hepatic disease is central to the design of future therapeutics. Our genome 
and proteome analyses (Fig. 5) identified differentially-regulated genes known 
to have an association with A1ATD (e.g. proteins of the ER-associated 
degradation machinery) as well as novel factors required to recognise and 
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bind mutant glycoproteins, retro-translocate them from the ER lumen to the 
cytosol and tag them for proteasomal degradation. With the reassurance 
provided by this biological baseline, we also identified molecules that could 
offer insights into the pathophysiology of disease using transcriptomics and 
proteomics. The twenty highest-expressed, differentially upregulated genes in 
ZZ-HLCs were all of mitochondrial origin and associated with tasks of meeting 
higher energy demands. This manifested as physical disruption of the 
mitochondria (Fig. 6D) which although described previously [44], is not yet 
comprehensively characterised with respect to its key molecular participants 
[45]. Our data provide new insight into the link between ER misfolding and 
mitochondrial disruption. Of particular interest, ER-stress response proteins 
ARMET (MANF) [46], OASIS (CREB3L1) [47], quality control chaperone 
proteins (HSP90 [48], Calreticulin [49], Calnexin [50]) and pro-inflammatory 
chemokines, cytokines and receptors (“inflammasome”) known to mediate 
cytotoxic stress and inflammation (IL-1, IL-18, Caspase-4, TNF,) [51] [52] 
were upregulated in ZZ-HLCs. Interestingly, of the five most highly 
upregulated genes in ZZ-HLCs reported by Wilson et al., CASP4 and CFH 
also appeared in our list of 1675 significant genes differentially regulated 
between ZZ-HLCs and RR-HLCs (FDR < 5%) [32]. We therefore propose 
these targets, known also to mediate inter-organelle communication, as 
potentially being pivotal to disease and worthy of further research. Finally, this 
work also indicates that a more direct drug screening approach to target these 






1. Byth, B.C., G.D. Billingsley, and D.W. Cox, Physical and genetic 
mapping of the serpin gene cluster at 14q32.1: allelic association and 
a unique haplotype associated with alpha 1-antitrypsin deficiency. Am 
J Hum Genet, 1994. 55(1): p. 126-33. 
2. Morrison, H.M., S.C. Afford, and R.A. Stockley, Inhibitory capacity of 
alpha 1 antitrypsin in lung secretions: variability and the effect of drugs. 
Thorax, 1984. 39(7): p. 510-6. 
3. Luisetti, M. and N. Seersholm, Alpha1-antitrypsin deficiency. 1: 
epidemiology of alpha1-antitrypsin deficiency. Thorax, 2004. 59(2): p. 
164-9. 
4. Haq, I., et al., Deficiency Mutations of Alpha-1 Antitrypsin. Effects on 
Folding, Function, and Polymerization. Am J Respir Cell Mol Biol, 
2016. 54(1): p. 71-80. 
5. Duvoix, A., B.D. Roussel, and D.A. Lomas, Molecular pathogenesis of 
alpha-1-antitrypsin deficiency. Rev Mal Respir, 2014. 31(10): p. 992-
1002. 
6. Laurell, C.B. and S. Eriksson, The electrophoretic alpha1-globulin 
pattern of serum in alpha1-antitrypsin deficiency. 1963. COPD, 2013. 
10 Suppl 1: p. 3-8. 
7. Carlson, J.A., et al., Accumulation of PiZ antitrypsin causes liver 
damage in transgenic mice. J Clin Invest, 1989. 83: p. 1183-1190. 
8. Gosai, S.J., et al., Automated high-content live animal drug screening 
using C. elegans expressing the aggregation prone serpin alpha1-
antitrypsin Z. PLoS One, 2010. 5(11): p. e15460. 
  
 22 
9. Ordonez, A., et al., Endoplasmic reticulum polymers impair luminal 
protein mobility and sensitize to cellular stress in alpha1-antitrypsin 
deficiency. Hepatology, 2013. 57(5): p. 2049-60. 
10. Takahashi, K. and S. Yamanaka, Induction of pluripotent stem cells 
from mouse embryonic and adult fibroblast cultures by defined factors. 
Cell, 2006. 126: p. 663-676. 
11. Rashid, S.T., et al., Modeling inherited metabolic disorders of the liver 
using human induced pluripotent stem cells. J Clin Invest, 2010. 
120(9): p. 3127-36. 
12. Tafaleng, E.N., et al., Induced pluripotent stem cells model 
personalized variations in liver disease resulting from alpha1-
antitrypsin deficiency. Hepatology, 2015. 62(1): p. 147-57. 
13. Yusa, K., et al., Targeted gene correction of α1-antitrypsin deficiency in 
induced pluripotent stem cells. Nature, 2011. 478(7369): p. 391-394. 
14. Hannan, N.R., et al., Production of hepatocyte-like cells from human 
pluripotent stem cells. Nat Protoc, 2013. 8(2): p. 430-437. 
15. Rouhani, F., et al., Genetic background drives transcriptional variation 
in human induced pluripotent stem cells. PLoS Genet, 2014. 10(6): p. 
e1004432. 
16. Baxter, M., et al., Phenotypic and functional analyses show stem cell-
derived hepatocyte-like cells better mimic fetal rather than adult 
hepatocytes. J Hepatol, 2015. 62(3): p. 581-9. 
17. American Thoracic, S. and S. European Respiratory, American 
Thoracic Society/European Respiratory Society statement: standards 
for the diagnosis and management of individuals with alpha-1 
  
 23 
antitrypsin deficiency. Am J Respir Crit Care Med, 2003. 168(7): p. 
818-900. 
18. Snapp, E.L., N. Altan, and J. Lippincott-Schwartz, Measuring protein 
mobility by photobleaching GFP chimeras in living cells. Curr Protoc 
Cell Biol, 2003. Chapter 21: p. Unit 21 1. 
19. Dickens, J.A., et al., The endoplasmic reticulum remains functionally 
connected by vesicular transport after its fragmentation in cells 
expressing Z-alpha1-antitrypsin. FASEB J, 2016. 
20. Costantini, L.M., et al., Assessing the tendency of fluorescent proteins 
to oligomerize under physiologic conditions. Traffic, 2012. 13(5): p. 
643-9. 
21. Lippincott-Schwartz, J., E. Snapp, and A. Kenworthy, Studying protein 
dynamics in living cells. Nat Rev Mol Cell Biol, 2001. 2(6): p. 444-56. 
22. Schmidt, B.Z. and D.H. Perlmutter, Grp78, Grp94, and Grp170 interact 
with alpha1-antitrypsin mutants that are retained in the endoplasmic 
reticulum. Am J Physiol Gastrointest Liver Physiol, 2005. 289(3): p. 
G444-55. 
23. Lawless, M.W., et al., Activation of endoplasmic reticulum-specific 
stress responses associated with the conformational disease Z alpha 
1-antitrypsin deficiency. J Immunol, 2004. 172(9): p. 5722-6. 
24. Chambers, J.E. and S.J. Marciniak, Cellular mechanisms of 
endoplasmic reticulum stress signaling in health and disease. 2. 
Protein misfolding and ER stress. Am J Physiol Cell Physiol, 2014. 
307(8): p. C657-70. 
  
 24 
25. Yeung, E.N., et al., Fibrinogen production is enhanced in an in-vitro 
model of non-alcoholic fatty liver disease: an isolated risk factor for 
cardiovascular events? Lipids Health Dis, 2015. 14: p. 86. 
26. Gao, H.J., et al., Quantitative proteomic analysis for high-throughput 
screening of differential glycoproteins in hepatocellular carcinoma 
serum. Cancer Biol Med, 2015. 12(3): p. 246-54. 
27. Matouk, I.J., et al., The H19 non-coding RNA is essential for human 
tumor growth. PLoS One, 2007. 2(9): p. e845. 
28. Deng, B., et al., MiRNA-211 suppresses cell proliferation, migration 
and invasion by targeting SPARC in human hepatocellular carcinoma. 
Sci Rep, 2016. 6: p. 26679. 
29. Divella, R., et al., Influence of plasminogen activator inhibitor-1 
(SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen 
expression in HCC associated with viral infection. Cancer Genomics 
Proteomics, 2012. 9(4): p. 193-8. 
30. Miranda, E., et al., A novel monoclonal antibody to characterize 
pathogenic polymers in liver disease associated with alpha1-antitrypsin 
deficiency. Hepatology, 2010. 52(3): p. 1078-88. 
31. Teckman, J.H., et al., Mitochondrial autophagy and injury in the liver in 
[alpha]1-antitrypsin deficiency. Am J Physiol, 2004. 286: p. G851-
G862. 
32. Wilson, A.A., et al., Emergence of a stage-dependent human liver 
disease signature with directed differentiation of alpha-1 antitrypsin-
deficient iPS cells. Stem Cell Reports, 2015. 4(5): p. 873-85. 
  
 25 
33. Baxter, M., et al., Phenotypic and functional analyses show stem cell-
derived hepatocyte-like cells better mimic fetal rather than adult 
hepatocytes. J Hepatol, 2014. 
34. Sveger, T., The natural history of liver disease in alpha 1-antitrypsin 
deficient children. Acta Paediatr Scand, 1988. 77(6): p. 847-51. 
35. Snapp, E.L., et al., Monitoring chaperone engagement of substrates in 
the endoplasmic reticulum of live cells. Proc Natl Acad Sci U S A, 
2006. 103(17): p. 6536-41. 
36. Lindblad, D., K. Blomenkamp, and J. Teckman, Alpha-1-antitrypsin 
mutant Z protein content in individual hepatocytes correlates with cell 
death in a mouse model. Hepatology, 2007. 46: p. 1228-1235. 
37. Granell, S. and G. Baldini, Inclusion bodies and autophagosomes: are 
ER-derived protective organelles different than classical 
autophagosomes? Autophagy, 2008. 4(3): p. 375-7. 
38. Smith, S.E., et al., Activating transcription factor 6 limits intracellular 
accumulation of mutant alpha(1)-antitrypsin Z and mitochondrial 
damage in hepatoma cells. J Biol Chem, 2011. 286(48): p. 41563-77. 
39. Laffin, B. and J.M. Petrash, Expression of the Aldo-Ketoreductases 
AKR1B1 and AKR1B10 in Human Cancers. Front Pharmacol, 2012. 3: 
p. 104. 
40. Jin, J., et al., Aldo-keto Reductase Family 1 Member B 10 Mediates 
Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate. Sci 
Rep, 2016. 6: p. 22746. 
41. Jedeszko, C. and B.F. Sloane, Cysteine cathepsins in human cancer. 
Biol Chem, 2004. 385(11): p. 1017-27. 
  
 26 
42. Leto, G., et al., Lysosomal cathepsins B and L and Stefin A blood 
levels in patients with hepatocellular carcinoma and/or liver cirrhosis: 
potential clinical implications. Oncology, 1997. 54(1): p. 79-83. 
43. Eriksson, S., J. Carlson, and R. Velez, Risk of cirrhosis and primary 
liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med, 1986. 
314(12): p. 736-9. 
44. Perlmutter, D.H., Liver injury in alpha1-antitrypsin deficiency: an 
aggregated protein induces mitochondrial injury. J Clin Invest, 2002. 
110(11): p. 1579-83. 
45. Teckman, J.H., et al., Mitochondrial autophagy and injury in the liver in 
alpha 1-antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol, 
2004. 286(5): p. G851-62. 
46. Apostolou, A., et al., Armet, a UPR-upregulated protein, inhibits cell 
proliferation and ER stress-induced cell death. Exp Cell Res, 2008. 
314(13): p. 2454-67. 
47. Kondo, S., et al., OASIS, a CREB/ATF-family member, modulates 
UPR signalling in astrocytes. Nat Cell Biol, 2005. 7(2): p. 186-94. 
48. Altieri, D.C., Hsp90 regulation of mitochondrial protein folding: from 
organelle integrity to cellular homeostasis. Cell Mol Life Sci, 2013. 
70(14): p. 2463-72. 
49. Ramos, R.R., A.J. Swanson, and J. Bass, Calreticulin and Hsp90 
stabilize the human insulin receptor and promote its mobility in the 




50. Cameron, P.H., et al., Calnexin phosphorylation attenuates the release 
of partially misfolded alpha1-antitrypsin to the secretory pathway. J 
Biol Chem, 2009. 284(50): p. 34570-9. 
51. Shimada, K., et al., Oxidized mitochondrial DNA activates the NLRP3 
inflammasome during apoptosis. Immunity, 2012. 36(3): p. 401-14. 
52. Lazarou, M., Keeping the immune system in check: a role for 
mitophagy. Immunol Cell Biol, 2015. 93(1): p. 3-10. 
 
FIGURE LEGENDS: 
Fig. 1. Validating a cellular platform suitable for in-depth disease 
characterisation. (A) qPCR analyses for the denoted genes in ZZ- (mutant, 
n=12) and RR- (corrected, n=12) HLCs vs. positive controls (plated and fresh, 
cryopreserved human primary hepatocytes, n=2-3). (B) DELFIA of secreted α1-
antitrypsin and albumin in ZZ- and RR-HLCs; n=3-9. (C) Immunostaining of ZZ 
and RR-HLCs for HNFα, α1-antitrypsin or albumin. Scale bar: 100 µm. (D) Pulse-
chase analysis: Radioactively-labelled, newly-synthesised protein was tracked 
from the intracellular (lysate) to extracellular space (supernatant) at 1h, 2h and 
4h.  
 
Fig. 2. ZZ-HLCs display heterogenous abnormal ER morphology. (A) ER 
marker GFP-KDEL shows the different types of abnormal ER morphologies 
observed in ZZ-HLCs vs RR-HLCs. (B) Quantification of each ER morphology. 
 
Fig. 3. Fluorescence loss in photobleaching (FLIP) shows absence of intra-
cellular exchanges between ER inclusions. (A) FLIP of ZZ- and RR-HLCs 
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transfected with KDEL-GFP: Pre-bleach fluorescence was determined before 
bleaching. Fluorescence was monitored within equidistant areas (stars) from the 
area of bleach (red box). Graphs show normalized FLIP plots with pre-bleach 
intensities set to 100 %. N=5. (B) FLIP of ZZ-HLCs with large inclusions 
transfected with CytERM. Graph shows normalised FLIP plot with pre-bleach 
intensities set to 100%. N=3. (C) 100 µm Z-tack image of ZZ-HLCs. Scale bars: 
10 µm. 
 
Fig. 4. Fluorescent recovery after photobleaching (FRAP) confirming 
decrease ER protein mobility in ZZ-HLCs. (A) KDEL-GFP transfected cells 
were exposed to a single bleaching event (white box). (B) Recovery of GFP 
fluorescence by way of diffusion into the bleached area was measured by 
tracking fluorescence within the bleached area. (C) Slope of the fluorescent 
recovery curve and the mobile fraction indicate a significantly lower degree of 
protein mobility and higher viscosity in ZZ-HLCs with inclusions. Statistical 
analysis by unpaired, parametric t-test: p ≤0.01 (**), p ≤0.0001 (****). 
  
Fig. 5. Proteomic and RNA-seq analyses capture novel disease signatures. 
(A) Experimental process for proteomic analyses. (B) List of  proteins identified in 
the ER proteome (green: present) and (red: absent) between ZZ- and RR-HLC. 
(C) MA plot shows log2 fold changes in gene expression between ZZ- and RR-
HLCs over the mean of normalised counts. Significant genes with Benjamini-
Hochberg FDR < 0.05 are shown in red. (D) 319 gene-protein pairs with 
differential abundances and gene expression were identified (blue, adjusted p-
values > 0.05 in red). (E) Most differentially expressed gene/protein pairs 
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upregulated (top) or downregulated (bottom). Horizontal lines: parameter 
boundaries of log2-fold change thresholds > 2 and < -2. (F) Data clustering 
showed the FPKM-based genes upregulated in ZZ-HLCs mapped into four 
groups: very high, high, low or very low expression. (G) Enriched gene ontology 
(GO) terms (p-value < 0.05) obtained from BioMart for the analysis of genes 
upregulated in ZZ-HLCs. 
 
Fig. 6. Clinical relevance of novel disease signatures. (A) Immunostaining of 
PiZZ patient liver tissue sections confirmed (green arrow) and absence (red 
arrow) of PAS-positive α1-antitrypsin globules (counter stained with polymer 
specific 2C1 antibody). Scale bar: 10 µm. (B) 1675 differentially regulated genes 
identified by RNA-seq of ZZ vs. RR-HLCs were compared to the top 1675 genes 
with the lowest p-values obtained by RNA-seq of one PiZZ vs. PiMM primary 
tissue sample. 80 genes were shared between the two gene lists. (C) AKR1B10 
immunostaining of liver sections (n=3 patients) with clinical backgrounds 
matching the original hIPSC donor’s. Staining with the 2C1 antibody confirmed 
presence of polymer in same cells as AKR1B10; negative controls (secondary 
antibody alone). Scale bar: 20 µm. (D) Electron microscopy comparing 
mitochondria in ZZ vs. RR-HLCs. Organelles with highly compressed morphology 
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Figure 5: Segeritz et al., 2015
PiZZ vs       ZZ-HLC vs
  PiMM          RR-HLC
A PiZZ patient liver tissue






(A) Histopathological staining of PiZZ patient liver tissue sections confirmed presence (green arrow) and absence (red arrow) of PAS-
positive α1-antitrypsin globules (counter stained with polymer specific 2C1 antibody) within the same PiZZ liver tissue. (B) 1675 
differentially regulated genes identified by RNA-seq of ZZ vs. RR-HLCs were compared to the top 1675 genes with the lowest p-values 
obtained by RNA-seq of one PiZZ vs. PiMM primary tissue sample. 959 genes (yellow) were upregulated in ZZ-HLCs, whilst 550 genes 
were upregulated in primary PiZZ tissue (purple). 80 genes were shared between the two gene lists. (C) Immunostaining of paraffin-
embedded liver sections taken from 3 patients with clinical backgrounds matching the original hIPSC donor’s stained positively for 
AKR1B10; one of the most highly enriched proteins common to ZZ-HLC and PiZZ RNA-seq / proteome datasets. Representative images 
taken from one patient’s sample. Staining with 2C1 antibody (left panel) confirmed presence of polymer in same cells as AKR1B10 (right 
panel); with absence of staining seen in representative image of negative controls (secondary antibody alone). Magnification 40x. (D) 
STRING Analysis was performed with the highest confidence view (score = 0.900) on the 959 genes upregulated in ZZ-HLCs. Each node 
represents a connected protein. Disconnected proteins are not shown. Interaction cluster [top] contained genes within inflammatory 
protein networks, including the pro-inflammatory chemokine IL-8. Interacting protein cluster [bottom] contained members with known 
involvement in molecular responses to stress and unfolded proteins. (E) Electron microscopy was used to compare mitochondrial 
phenotypes in ZZ vs. RR-HLCs. Whilst the majority of ZZ-HLCs exhibited normal mitochondrial phenotypes (left panels), almost half had 
deranged cristae in which multi-lamellar membranes were highly compressed to one side of the organelle, yielding heterogeneous electron 
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(A) Histopathological staining of PiZZ patient liver tissue sections confir ed presence (gre n arrow) and absence (red arrow) of PAS-
positive α1-antitrypsin globules (counter stained with polymer specific 2C1 antibody) ithin the same PiZZ liver tissue. (B) 1675 
differentially regulated genes identified by RNA-seq of ZZ vs. RR-HLCs were compared to the top 1675 genes with the lowest p-values 
obtained by RNA-seq of one PiZZ vs. PiMM primary tissue sample. 959 genes (yellow) were upregulated in ZZ-HLCs, whilst 550 genes 
were upregulated in primary PiZZ tissue (purple). 80 genes were shared between the two gene lists. (C) Immunostaining of paraffin-
embedded liver sections taken from 3 patients with clinical backgrounds matching the original hIPSC donor’s stained positively for 
AKR1B10; one of the most highly enriched proteins common to ZZ-HLC and PiZZ RNA-seq / proteome datasets. Representative images 
taken from one pati nt’s sample. Staining with 2C1 antibody (left panel) confirmed presence of polymer in same cells as AKR1B10 (right 
panel); with absence of staining seen in representative image of negative controls (secondary antibody alone). Magnification 40x. (D) 
STRING Analysis was performed with the highest confidence view (score = 0.900) on the 959 genes upregulated in ZZ-HLCs. Each node 
represents a connected protein. Disconnected proteins are not shown. Interaction cluster [top] contained genes within inflammatory 
protein networks, including the pro-inflammatory chemokine IL-8. Interacting protein cluster [bottom] contained members with known 
involvement in molecular responses to stress and unfolded proteins. (E) Electron microscopy was used to compare mitochondrial 
phenotypes in ZZ vs. RR-HLCs. Whilst the majority of ZZ-HLCs exhibited normal mitochondrial phenotypes (left panels), almost half had 
deranged cristae in which multi-lamellar membranes were highly compressed to one side of the organelle, yielding heterogeneous electron 
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(A) Histopathological staining of PiZZ patient liver tissue sections confirmed presence (green arrow) and absence (red arrow) of PAS-
positive α1-antitrypsin globules (counter stained with polymer specific 2C1 antibody) within the same PiZZ liver tissue. (B) 1675 
differentially regulated genes identified by RNA-seq of ZZ vs. RR-HLCs were compared to the top 1675 genes with the lowest p-values 
obtained by RNA-seq of one PiZZ vs. PiMM primary tissue sample. 959 genes (yellow) were upregulated in ZZ-HLCs, whilst 550 genes 
were upregulated in primary PiZZ tissue (purple). 80 genes were shared between the two gene lists. (C) Immunostaining of paraffin-
embedded liver sections taken from 3 patients with clinical backgrounds matching the original hIPSC donor’s stained positively for 
AKR1B10; one of the most highly enriched proteins common to ZZ-HLC and PiZZ RNA-seq / proteome datasets. Representative images 
taken from one patient’s sample. Staining with 2C1 antibody (left panel) confirmed presence of polymer in same cells as AKR1B10 (right 
panel); with absence of staining seen in representative image of negative controls (secondary antibody alone). Magnification 40x. (D) 
STRING Analysis was performed with the highest confidence view (score = 0.900) on the 959 genes upregulated in ZZ-HLCs. Each node 
represents a connected protein. Disconnected proteins are not shown. Interaction cluster [top] contained genes within inflammatory 
protein networks, including the pro-inflammatory chemokine IL-8. Interacting protein cluster [bottom] contained members with known 
involvement in molecular responses to stress and unfolded proteins. (E) Electron microscopy was used to compare mitochondrial 
phenotypes in ZZ vs. RR-HLCs. Whilst the majority of ZZ-HLCs exhibited normal mitochondrial phenotypes (left panels), almost half had 
deranged cristae in which multi-lamellar membranes were highly compressed to one side of the organelle, yielding heterogeneous electron 
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The novel disease signatures of A1AT are of direct clinical relevance. (A) Histopathological staining of PiZZ patient liver tissue 
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ed presence (green arrow) and absence (red arrow) of PAS-positive α
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polym
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e PiZZ liver tissue. (B) 1675 differentially regulated genes identified by RNA-seq of ZZ vs. 
RR-HLCs were com





ple. 959 genes (yellow) were upregulated in ZZ-HLCs, whilst 550 genes were upregulated in prim
ary PiZZ tissue (purple). 80 genes 
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unostaining of paraffin-em
bedded liver sections taken from
 3 patients with clinical 
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atching the original hIPSC donor’s stained positively for AKR1B10; one of the m
ost highly enriched proteins com
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on to 
ZZ-HLC and PiZZ RNA-seq / proteom
e datasets. Representative im
ages taken from
 one patient’s sam
ple. Staining with 2C1 antibody (left 
panel) confirm
ed presence of polym
er in sam
e cells as AKR1B10 (right panel); with absence of staining seen in representative im
age of 
negative controls (secondary antibody alone). M
agnification 40x. (D) STRING
 Analysis was perform
ed with the highest confidence view 
(score = 0.900) on the 959 genes upregulated in ZZ-HLCs. Each node represents a connected protein. Disconnected proteins are not 
shown. Interaction cluster [top] contained genes within inflam
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] contained m
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olecular responses to stress and unfolded proteins. 
(E) Electron m
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hiPSC hepatocyte model demonstrates the role of unfolded protein response 








•  Modelling α1-antitrypsin deficiency liver disease using hiPSC-derived 
hepatocytes reveals disruption of the endoplasmic reticulum into 
isolated cisternae.   
• Comparative transcriptomic and proteomics between diseased hiPSC-
derived hepatocytes and their isogenic wildtype provides insights into 
disease mechanisms.  
• AKR1B10 was identified as a putative biomarker for α1-antitrypsin 
deficiency.  
 
 
